Abstract
This study evaluates antibiotic usage trends in a UK secondary care setting, comparing pre-pandemic (2019) and pandemic (2020) data. The focus is on antibiotic use among adults admitted for respiratory tract infections (RTIs) and pneumonia, assessed using the WHO AWaRe classification and Defined Daily Dose (DDD). Findings reveal a notable increase in "Watch" category antibiotics, particularly azithromycin, clarithromycin, and levofloxacin, reflecting shifts in prescribing practices likely driven by COVID-19. These increases underscore the need for enhanced antimicrobial stewardship to prevent exacerbation of AMR. The study highlights the importance of careful antibiotic management to ensure patient safety and combat AMR.
| Original language | English |
|---|---|
| Publication status | Published - 11 Nov 2024 |
| Event | Royal pharmaceutical society annual conference 2024: Working across boundaries: Embracing new opportunities and empowering excellence - Convene, 133 Houndsditch, London, United Kingdom Duration: 8 Nov 2024 → 8 Nov 2024 |
Conference
| Conference | Royal pharmaceutical society annual conference 2024 |
|---|---|
| Country/Territory | United Kingdom |
| City | London |
| Period | 8/11/24 → 8/11/24 |
Keywords
- Antimicrobial resistance (AMR)
- Antibiotic Use
- COVID-19 pandemic
- Antimicrobial stewardship (AMS)
- Secondary care
- Defined Daily Dose (DDD)
- WHO AWaRe classification
- Respiratory tract infections (RTIs)
- Prescribing trends
- Levofloxacin
- Antibiotic prescribing trends
- Macrolide
- Macrolides/pharmacology
- antibiotic classification
- Antibiotic guardian
- Antibiotic Guidelines
- Antibiotic Prescribing
- Antibiotic research
- Antibiotic resistance
- Antibiotic Safety Measures
- Antibiotic Stewardship
- WHO guidelines